As of 2025-01-21, the Relative Valuation of Resmed Inc (RMD) is 297.79 USD. This relative valuation is based on P/E multiples. With the latest stock price at 239.78 USD, the upside of Resmed Inc based on Relative Valuation is 24.2%.
The range of the Relative Valuation is 247.00 - 353.57 USD.
| Range | Selected | |
| Trailing P/E multiples | 39.0x - 46.6x | 43.7x |
| Forward P/E multiples | 29.4x - 37.5x | 31.5x |
| Fair Price | 247.00 - 353.57 | 297.79 |
| Upside | 3.0% - 47.5% | 24.2% |
| Date | P/E |
| 2025-01-17 | 31.63 |
| 2025-01-16 | 31.28 |
| 2025-01-15 | 30.79 |
| 2025-01-14 | 30.18 |
| 2025-01-13 | 30.37 |
| 2025-01-10 | 30.84 |
| 2025-01-08 | 31.15 |
| 2025-01-07 | 31.18 |
| 2025-01-06 | 31.01 |
| 2025-01-03 | 30.56 |
| 2025-01-02 | 30.14 |
| 2024-12-31 | 30.17 |
| 2024-12-30 | 30.27 |
| 2024-12-27 | 30.76 |
| 2024-12-26 | 30.85 |
| 2024-12-24 | 30.68 |
| 2024-12-23 | 30.49 |
| 2024-12-20 | 31.30 |
| 2024-12-19 | 30.55 |
| 2024-12-18 | 30.37 |
| 2024-12-17 | 32.00 |
| 2024-12-16 | 31.79 |
| 2024-12-13 | 31.46 |
| 2024-12-12 | 31.99 |
| 2024-12-11 | 32.42 |
| 2024-12-10 | 32.35 |
| 2024-12-09 | 32.29 |
| 2024-12-06 | 31.84 |
| 2024-12-05 | 31.58 |
| 2024-12-04 | 32.43 |
| 2024-12-03 | 32.57 |
| 2024-12-02 | 32.31 |
| 2024-11-29 | 32.85 |
| 2024-11-27 | 32.89 |
| 2024-11-26 | 32.98 |
| 2024-11-25 | 32.92 |
| 2024-11-22 | 32.16 |
| 2024-11-21 | 32.13 |
| 2024-11-20 | 31.86 |
| 2024-11-19 | 31.41 |
| 2024-11-18 | 31.58 |
| 2024-11-15 | 30.96 |
| 2024-11-14 | 30.53 |
| 2024-11-13 | 31.06 |
| 2024-11-12 | 32.61 |
| 2024-11-11 | 32.80 |
| 2024-11-08 | 33.29 |
| 2024-11-07 | 32.78 |
| 2024-11-06 | 32.40 |
| 2024-11-05 | 32.42 |